Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Viela Bio

Viela Bio
2017 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
VIE STOCK SYMBOL
$26.15 SHARE PRICE (As of Wednesday Closing)
Description

Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • One MedImmune Way
  • First Floor, Area Two
  • Gaithersburg, MD 20878
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Viela Bio’s full profile, request a free trial.

Viela Bio Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$18.20 - $33.70 $1.33B $26.00 $17.5M 163K 51M

Viela Bio Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
Revenue 20,000 0
EBITDA (92,350) (192,294)
Net Income (89,913) (190,270)
Total Assets 233,840 139,827
Total Debt 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Viela Bio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Viela Bio‘s full profile, request access.

Request full access to PitchBook

Viela Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Viela Bio‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Viela Bio Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apitope International Venture Capital-Backed Diepenbeek, Belgium 0 000.00 00000000000 000.00
00000000 000000000 Venture Capital-Backed Boston, MA 000 00.000 0000000000 0 00.000
000000000 00000000 Venture Capital-Backed San Diego, CA 00 0000 00000000000 0000
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
0000000 000000 Formerly VC-backed Redwood City, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Viela Bio Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Viela Bio‘s full profile, request access.

Request full access to PitchBook

Viela Bio Executive Team (7)

Name Title Board
Seat
Contact
Info
Zhengbin Yao Ph.D Chief Executive Officer & Chairman
Aaron Ren Ph.D Executive & Vice President
Jorn Drappa Ph.D Chief Medical Officer & Executive
Soraya Madani Ph.D Vice President & Head of Portfolio Management and Regulatory Affairs
Mitchell Chan Chief Financial Officer

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Viela Bio Board Members (12)

Name Representing Role Since Contact
Info
Andreas Wicki Ph.D Self Board Member 000 0000
Edward Hu Ph.D 6 Dimensions Capital Board Member 000 0000
Pascal Soriot Self Board Member 000 0000
Sean Tong Boyu Capital Board Member 000 0000
Tyrell Rivers Ph.D Viela Bio Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »